Expect Less Concern Over Psychiatric Effects With Champix

You'll see less concern about psychiatric events with Champix (varenicline) or Zyban (bupropion SR) for smoking cessation.

Warnings about mood changes, agitation, nightmares, and other psychiatric risks are based on case reports.

Now a large trial suggests that these meds do NOT increase psychiatric side effects in patients quitting smoking.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote